ResMed Inc. (RMD) Stock Analysis

ResMed Inc. (RMD) Stock Analysis — AI Research | MarketCI

RMD

Market Closed

ResMed Inc.

NYSEHealthcare Medical - Devices

9.98K employees

CEO: Michael J. Farrell

Founded: 1995

$188.63

+$0.00(+NaN%)

Market Cap

27.36B

Beta

0.78

52W Range

N/A

Dividend Yield

1.27%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

RMD Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for RMD built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Buy

Pass %

71.43%

Score

5/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$309.17

AI Price Target

Machine learning • Price prediction

$168.04

Market Sentiment

News & social media analysis

0.07

Value Investor Price

Classic value analysis

$52.10

Financial Health

Bankruptcy risk assessment

10.48

Quality Score

Financial strength rating

7.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting RMD investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

83.72% Excellent

Conditions Met

36.00/43.00

Due Diligence Score

83.72%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions